Detalles de la búsqueda
1.
The evolution of risk factors for respiratory syncytial virus-related hospitalisation in infants born at 32-35 weeks' gestational age: time-based analysis using data from the FLIP-2 study.
J Perinat Med
; 40(6): 685-91, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23093079
2.
FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
Pediatr Infect Dis J
; 27(9): 788-93, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18664927
3.
A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study.
Respir Res
; 9: 78, 2008 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-19063742
4.
Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?
J Matern Fetal Neonatal Med
; 28(10): 1133-41, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25048748
5.
Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain.
Pediatr Infect Dis J
; 23(9): 815-20, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15361718
6.
Identifying risk factors for severe respiratory syncytial virus among infants born after 33 through 35 completed weeks of gestation: different methodologies yield consistent findings.
Pediatr Infect Dis J
; 23(11 Suppl): S193-201, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15577573
7.
Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
Pediatr Infect Dis J
; 22(9): 823-7, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-14506376
8.
Effects of parental and household smoking on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm infants and the potential impact of RSV prophylaxis.
J Matern Fetal Neonatal Med
; 26(9): 926-31, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23379728
9.
Serum soluble ICAM-1, VCAM-1, L-selectin, and P-selectin levels as markers of infection and their relation to clinical severity in neonatal sepsis.
Am J Perinatol
; 24(6): 331-8, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17564956
10.
Antenatal glucocorticoid treatment decreases mortality and chronic lung disease in survivors among 23- to 28-week gestational age preterm infants.
Am J Perinatol
; 22(8): 441-8, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16283604
11.
Plasma endothelin-1 and clinical manifestations of neonatal sepsis.
J Perinat Med
; 32(6): 522-6, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15576275
12.
Concerning the article by s. Belda et Al.: screening for retinopathy of prematurity: is it painful?
Biol Neonate
; 89(3): 197; author reply 198, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16299409
13.
Antenatal glucocorticoid treatment increases the rate of "survival without chronic lung disease" among 25- to 29-week preterm infants.
J Pediatr
; 140(4): 486-7; author reply 487, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12006971
Resultados
1 -
13
de 13
1
Próxima >
>>